A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.
Xia, S., Yan, L., Xu, W., Agrawal, A.S., Algaissi, A., Tseng, C.K., Wang, Q., Du, L., Tan, W., Wilson, I.A., Jiang, S., Yang, B., Lu, L.(2019) Sci Adv 5: eaav4580-eaav4580
- PubMed: 30989115 
- DOI: 10.1126/sciadv.aav4580
- Primary Citation of Related Structures:  
5ZUV, 5ZVK, 5ZVM - PubMed Abstract: 
Continuously emerging highly pathogenic human coronaviruses (HCoVs) remain a major threat to human health, as illustrated in past SARS-CoV and MERS-CoV outbreaks. The development of a drug with broad-spectrum HCoV inhibitory activity would address this urgent unmet medical need ...